# Alzheimer's disease research advances

> Live situation record from CLSTR: https://clstr.news/situations/alzheimers-disease-research-advances
> Updated: 2026-08-01T00:03:51.000Z. Sources: 13. Developments: 3.

In late July 2026, researchers reported two distinct but complementary breakthroughs in Alzheimer’s disease science. On July 20, a University of Kentaki team showed that overactive microglia impair deep NREM sleep in mouse models, and that dampening microglial activity restores several hours of restorative sleep each day. The same conference featured Biogen’s antisense oligonucleotide dinranesine, which cut cerebrospinal‑fluid tau by up to 70 % and slowed cognitive decline by 26 % in a 400‑patient trial, with the lowest dose delivering the greatest benefit.

Two days later, scientists described a fundamental disruption of three‑dimensional genome organization in human brain cells affected by Alzheimer’s, linking compartment mingling to synaptic loss, metabolic stress and microglial senescence. Parallel work on aging brains revealed replacement of embryonic microglia with blood‑like immune cells, heightening inflammation. In mouse experiments, boosting the SORLA protein limited tau spread, preserved neuronal connections and reduced harmful inflammation, pointing to a new therapeutic avenue.

Subsequent analyses deepened these insights. High‑resolution single‑cell GAGE‑seq, spatial transcriptomics and a deep‑learning model (Hicformer) confirmed that loss of chromatin compartmentalization weakens gene‑regulatory contacts across cell types and coincides with loss of blood‑brain‑barrier cells. A separate study of microglial phenotypes across Alzheimer’s patients, cognitively resilient elders and centenarians identified activation states associated with preserved cognition. In parallel, researchers linked a bacterial signature—particularly Porphyromonas gingivalis in oral and gut microbiota—to neuroinflammation, amyloid accumulation and cognitive decline, suggesting microbiome‑based biomarkers and preventive strategies.

## Timeline

### 2026-08-01: Alzheimer's research links brain immune cells and bacterial signature

New studies link microglial activity and oral‑gut bacterial signatures to Alzheimer’s progression, offering potential biomarkers and therapeutic directions.

2 sources. https://clstr.news/cluster/alzheimers-research-links-brain-immune-cells-and-bacterial-signature

### 2026-07-22: Alzheimer's research reveals 3D genome disruption and protective protein effects on disease

New studies link 3D genome disruption and microglial changes to Alzheimer's, while boosting SORLA protein reduces tau spread, offering therapeutic hope.

6 sources. https://clstr.news/cluster/alzheimers-research-reveals-3d-genome-disruption-and-protective-protein-effects-on-disease

### 2026-07-20: Alzheimer's research uncovers sleep‑linked microglia role and experimental antisense drug slows disease

Greek study links microglia‑driven sleep loss to Alzheimer’s, while Biogen’s antisense drug reduces tau and slows cognitive decline by about a quarter.

5 sources. https://clstr.news/cluster/alzheimers-research-uncovers-sleeplinked-microglia-role-and-experimental-antisense-drug-slows-diseas

---
Cite as: Alzheimer's disease research advances. CLSTR, https://clstr.news/situations/alzheimers-disease-research-advances